<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27950">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02742857</url>
  </required_header>
  <id_info>
    <org_study_id>BQ12016</org_study_id>
    <secondary_id>AAH -01-2016</secondary_id>
    <nct_id>NCT02742857</nct_id>
  </id_info>
  <brief_title>Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury</brief_title>
  <official_title>Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multimodality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bioquark Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Revita Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Anupam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bioquark Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is the proof of concept study with multi-modality approach (using intra-thecal
      bioactive peptides, stem cells, laser and transcranial IV laser and Median Nerve stimulation
      as adjuvants) in cases of brain death due to traumatic brain injury having diffuse axonal
      injury to document possibility of reversal of brain death (BD).
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>July 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reversal of brain death as noted in clinical examination or EEG</measure>
    <time_frame>15 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cerebrospinal fluid (CSF) analysis of color consistency, cell counts, and microbial evaluation</measure>
    <time_frame>15 days</time_frame>
    <description>To signify any signs of aseptic or bacterial meningitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI analysis to analyze any changes in meninges</measure>
    <time_frame>15 days</time_frame>
    <description>To signify any signs of aseptic or bacterial meningitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>O2 saturation</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration changes</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Brain Death</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>BQ-A Peptide Extract</intervention_name>
    <description>BQ-A Peptide Extract</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Mesenchymal Stem Cells</intervention_name>
    <description>Mesenchymal Stem Cells</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Laser Therapy</intervention_name>
    <description>Transcranial Laser Therapy</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Median Nerve Stimulator</intervention_name>
    <description>Median Nerve Stimulator</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals declared Brain dead from a traumatic brain injury having diffuse axonal
             injury on MRI

          -  Not willing for organ donation

          -  Written informed consent from the legally acceptable representative of the patient

        Exclusion Criteria:

          -  Metallic clips/ metal implants or intracranial implants in the brain.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 12, 2016</lastchanged_date>
  <firstreceived_date>April 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Brain Death</mesh_term>
    <mesh_term>Diffuse Axonal Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
